Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome

Abstract

2 mg of intravitreal TA is effective even in cases of resistant uveitic CMO. Although re-treatment is often required, the initial response to treatment can be maintained by subsequent orbital floor steroid injections.